Literature DB >> 11403223

Human mast cell apoptosis is regulated through Bcl-2 and Bcl-XL.

Y A Mekori1, A M Gilfillan, C Akin, K Hartmann, D D Metcalfe.   

Abstract

It is well established that human mast cell proliferation and maturation are regulated by kit ligand (stem cell factor). Little is known, however, about how these two processes are negatively regulated and thus, how mast cell number is controlled in normal and pathologic conditions. We therefore first hypothesized that SCF-dependent human mast cells would undergo programmed cell death (apoptosis) on removal of SCF as has been shown for growth factor-dependent rodent mast cells. We then examined whether SCF acts as a survival factor through the regulation of the bcl-2 family of apoptosis-regulatory genes. As hypothesized, elimination of SCF from primary peripheral blood-derived human mast cell cultures resulted in a significant apoptotic process. During apoptosis, down-regulation of the two apoptosis-regulatory proteins Bcl-2 and Bcl-XL was observed. Moreover, a deregulated expression of these two proteins was found in two human mast cell lines which are SCF-independent. Thus, SCF functions as a survival factor by repressing apoptosis of human mast cells through Bcl-2 and Bcl-XL. Deregulated expression of these antiapoptotic proteins may contribute to proliferation and accumulation of mast cells in certain forms of systemic mast cell disorders.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11403223     DOI: 10.1023/a:1011083031272

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  11 in total

1.  A role for Bax in the regulation of apoptosis in mouse mast cells.

Authors:  M Maurer; M Tsai; M Metz; S Fish; S J Korsmeyer; S J Galli
Journal:  J Invest Dermatol       Date:  2000-06       Impact factor: 8.551

Review 2.  Kit signal transduction.

Authors:  M L Taylor; D D Metcalfe
Journal:  Hematol Oncol Clin North Am       Date:  2000-06       Impact factor: 3.722

3.  Characterization of a mast cell line that lacks the extracellular domain of membrane c-kit.

Authors:  Y A Mekori; C K Oh; J Dastych; J P Goff; S Adachi; P J Bianchine; A Worobec; T Semere; J H Pierce; D D Metcalfe
Journal:  Immunology       Date:  1997-04       Impact factor: 7.397

4.  Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through Bcl-XL and Bcl-2.

Authors:  M Silva; D Grillot; A Benito; C Richard; G Nuñez; J L Fernández-Luna
Journal:  Blood       Date:  1996-09-01       Impact factor: 22.113

5.  Expression of Bcl-x in erythroid precursors from patients with polycythemia vera.

Authors:  M Silva; C Richard; A Benito; C Sanz; I Olalla; J L Fernández-Luna
Journal:  N Engl J Med       Date:  1998-02-26       Impact factor: 91.245

6.  Expression of Bcl-2 by human bone marrow mast cells and its overexpression in mast cell leukemia.

Authors:  C Cerveró; L Escribano; J F San Miguel; B Díaz-Agustín; P Bravo; J Villarrubia; R García-Sanz; J L Velasco; P Herrera; M Vargas; M González; J L Navarro; A Orfao
Journal:  Am J Hematol       Date:  1999-03       Impact factor: 10.047

7.  Glucocorticoids decrease tissue mast cell number by reducing the production of the c-kit ligand, stem cell factor, by resident cells: in vitro and in vivo evidence in murine systems.

Authors:  S Finotto; Y A Mekori; D D Metcalfe
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

8.  The expression of Bcl-x is downregulated during differentiation of human hematopoietic progenitor cells along the granulocyte but not the monocyte/macrophage lineage.

Authors:  C Sanz; A Benito; M Silva; B Albella; C Richard; J C Segovia; A Insunza; J A Bueren; J L Fernández-Luna
Journal:  Blood       Date:  1997-05-01       Impact factor: 22.113

Review 9.  Regulation of lymphocyte survival by the bcl-2 gene family.

Authors:  S Cory
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

10.  Mast cells cultured from the peripheral blood of normal donors and patients with mastocytosis originate from a CD34+/Fc epsilon RI- cell population.

Authors:  M Rottem; T Okada; J P Goff; D D Metcalfe
Journal:  Blood       Date:  1994-10-15       Impact factor: 22.113

View more
  16 in total

Review 1.  Mastocytosis and disorders of mast cell proliferation.

Authors:  Joanne K Simpson; Dean D Metcalfe
Journal:  Clin Rev Allergy Immunol       Date:  2002-04       Impact factor: 8.667

Review 2.  Mast cell homeostasis and the JAK-STAT pathway.

Authors:  J K Morales; Y T Falanga; A Depcrynski; J Fernando; J J Ryan
Journal:  Genes Immun       Date:  2010-06-10       Impact factor: 2.676

3.  IL-33/ST2 axis promotes mast cell survival via BCLXL.

Authors:  Jun-Xia Wang; Shinjiro Kaieda; Sarah Ameri; Nadia Fishgal; Daniel Dwyer; Anthony Dellinger; Christopher L Kepley; Michael F Gurish; Peter A Nigrovic
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-30       Impact factor: 11.205

4.  A subset of virus-specific CD161+ T cells selectively express the multidrug transporter MDR1 and are resistant to chemotherapy in AML.

Authors:  Abdullah Alsuliman; Muharrem Muftuoglu; Ahmad Khoder; Yong-Oon Ahn; Rafet Basar; Michael R Verneris; Pawel Muranski; A John Barrett; Enli Liu; Li Li; Kate Stringaris; Darius Armstrong-James; Hila Shaim; Kayo Kondo; Nobuhiko Imahashi; Borje Andersson; David Marin; Richard E Champlin; Elizabeth J Shpall; Katayoun Rezvani
Journal:  Blood       Date:  2016-11-07       Impact factor: 22.113

5.  Glycogen synthase kinase-3β is a prosurvival signal for the maintenance of human mast cell homeostasis.

Authors:  Madeleine Rådinger; Daniel Smrž; Dean D Metcalfe; Alasdair M Gilfillan
Journal:  J Immunol       Date:  2011-10-28       Impact factor: 5.422

Review 6.  Development, migration, and survival of mast cells.

Authors:  Yoshimichi Okayama; Toshiaki Kawakami
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 7.  Mast cell growth, differentiation, and death.

Authors:  Michael F Gurish; Joshua A Boyce
Journal:  Clin Rev Allergy Immunol       Date:  2002-04       Impact factor: 8.667

8.  Expression of Bcl-2 and Bcl-xL in cutaneous and bone marrow lesions of mastocytosis.

Authors:  Karin Hartmann; Metin Artuc; Stephan E Baldus; Thomas K Zirbes; Barbara Hermes; Juergen Thiele; Yoseph A Mekori; Beate M Henz
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

9.  Endogenous suppression of mast cell development and survival by IL-4 and IL-10.

Authors:  Kelly Speiran; Daniel P Bailey; Josephine Fernando; Matthew Macey; Brian Barnstein; Motunrayo Kolawole; Dana Curley; Stephanie S Watowich; Peter J Murray; Carole Oskeritzian; John J Ryan
Journal:  J Leukoc Biol       Date:  2009-02-19       Impact factor: 4.962

10.  Screening of candidate G-quadruplex ligands for the human c-KIT promotorial region and their effects in multiple in-vitro models.

Authors:  Eleonora Zorzan; Silvia Da Ros; Caterina Musetti; Lara Zorro Shahidian; Nuno Filipe Ramos Coelho; Federico Bonsembiante; Sébastien Létard; Maria Elena Gelain; Manlio Palumbo; Patrice Dubreuil; Mery Giantin; Claudia Sissi; Mauro Dacasto
Journal:  Oncotarget       Date:  2016-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.